Furacilin

CAS No. 59-87-0

Furacilin( Furacilin | Nitrofural | NSC 1602 | NSC 2100 | NSC 44009 )

Catalog No. M15226 CAS No. 59-87-0

Nitrofural is a bactericidal compound used as an antibiotic most commonly in the form of ointments.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1G 45 In Stock

Biological Information

  • Product Name
    Furacilin
  • Note
    Research use only, not for human use.
  • Brief Description
    Nitrofural is a bactericidal compound used as an antibiotic most commonly in the form of ointments.
  • Description
    Nitrofural is a bactericidal compound used as an antibiotic most commonly in the form of ointments.
  • In Vitro
    RT-PCR Cell Line:E. Coli stratin B/r Concentration:50 μg/mL Incubation Time:30 min Result:Inhibited the synthesis of 16 and 23s ribosomal RNA and 45 RNA.
  • In Vivo
    ——
  • Synonyms
    Furacilin | Nitrofural | NSC 1602 | NSC 2100 | NSC 44009
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Dehydrogenase
  • Recptor
    Malate dehydrogenase| Pyruvate dehydrogenase| Glutathione reductase
  • Research Area
    Infection
  • Indication
    ——

Chemical Information

  • CAS Number
    59-87-0
  • Formula Weight
    198.14
  • Molecular Formula
    C6H6N4O4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 40 mg/mL (201.87 mM)
  • SMILES
    O=[N+]([O-])C1=CC=C(/C=N/NC(N)=O)O1
  • Chemical Name
    (E)-2-((5-nitrofuran-2-yl)methylene)hydrazinecarboxamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Imming P, et al. Nat Rev Drug Discov. 2006 Oct; 5(10):821-34.
molnova catalog
related products
  • SW209049

    SW209049 is a stearoyl-CoA 9-desaturase inhibitor. SW209049 exhivits potent activity against H2122 cell with IC50 of 0.13uM.

  • DHODH-IN-13

    DHODH-IN-13 is the hydroxyfuran analogue of A771726.

  • ALDH1A3-IN-2

    ALDH1A3-IN-2 is a potent ALDH1A3 inhibitor with an IC50 of 0.30 μM.ALDH1A3-IN-2 has potential for cancer disease research.